Annual ROE
12.73%
+222.16%+106.08%
December 31, 2023
Summary
- As of February 22, 2025, AMLX annual return on equity is 12.73%, with the most recent change of +222.16% (+106.08%) on December 31, 2023.
- During the last 3 years, AMLX annual ROE has fallen by -50.63% (-79.91%).
- AMLX annual ROE is now -79.91% below its all-time high of 63.36%, reached on December 31, 2020.
Performance
AMLX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-79.41%
-33.94%-74.64%
September 30, 2024
Summary
- As of February 22, 2025, AMLX quarterly return on equity is -79.41%, with the most recent change of -33.94% (-74.64%) on September 30, 2024.
- Over the past year, AMLX quarterly ROE has dropped by -79.97% (-14280.36%).
- AMLX quarterly ROE is now -107.49% below its all-time high of 1060.80%, reached on March 31, 2022.
Performance
AMLX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AMLX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +106.1% | -10000.0% |
| 3 y3 years | -79.9% | -10000.0% |
| 5 y5 years | -76.5% | -10000.0% |
AMLX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.1% | +106.1% | -107.5% | +79.5% |
| 5 y | 5-year | -79.9% | +106.1% | -107.5% | +79.5% |
| alltime | all time | -79.9% | +106.1% | -107.5% | +79.5% |
Amylyx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -79.41%(+74.6%) |
| Jun 2024 | - | -45.47%(+145.0%) |
| Mar 2024 | - | -18.56%(-245.6%) |
| Dec 2023 | 12.73%(-106.1%) | 12.75%(+2176.8%) |
| Sep 2023 | - | 0.56%(-102.2%) |
| Jun 2023 | - | -25.70%(-55.6%) |
| Mar 2023 | - | -57.84%(-33.1%) |
| Dec 2022 | -209.43% | -86.40%(-49.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -172.54%(-55.4%) |
| Jun 2022 | - | -387.14%(-136.5%) |
| Mar 2022 | - | 1060.80%(+1560.4%) |
| Dec 2021 | 58.17%(-8.2%) | 63.89%(-10.6%) |
| Sep 2021 | - | 71.47%(+5.9%) |
| Jun 2021 | - | 67.50%(+94.9%) |
| Mar 2021 | - | 34.64%(+168.9%) |
| Dec 2020 | 63.36%(+17.1%) | 12.88% |
| Dec 2019 | 54.09% | - |
FAQ
- What is Amylyx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual ROE year-on-year change?
- What is Amylyx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly ROE year-on-year change?
What is Amylyx Pharmaceuticals annual return on equity?
The current annual ROE of AMLX is 12.73%
What is the all time high annual ROE for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual return on equity is 63.36%
What is Amylyx Pharmaceuticals annual ROE year-on-year change?
Over the past year, AMLX annual return on equity has changed by +222.16% (+106.08%)
What is Amylyx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AMLX is -79.41%
What is the all time high quarterly ROE for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly return on equity is 1060.80%
What is Amylyx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AMLX quarterly return on equity has changed by -79.97% (-14280.36%)